Phage-based nanomaterials for biomedical applications

Acta Biomaterialia

Volumn 10, Issue 4, 2014, Pages 1741-1750

  Farr, Rebecca ^a   Choi, Dong Shin ^a   Lee, Seung Wuk ^a  

^a University of California at Berkeley   (United States)

Author keywords

Bionanomedicine; Drug delivery; Phage therapy; Tissue engineering; Virus

Indexed keywords

CHEMICAL MODIFICATION; CONTROLLED DRUG DELIVERY; GENES; GENETIC ENGINEERING; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS; TARGETED DRUG DELIVERY; TISSUE; VIRUSES;

BIOLOGICAL PROPERTIES; BIOMEDICAL APPLICATIONS; BIONANOMEDICINE; BUILDING BLOCKES; CHEMICAL AND BIOLOGICALS; MOLECULAR LEVEL CONTROL; PHAGE THERAPY; PHYSICAL-CHEMICAL PROPERTIES; TISSUES ENGINEERINGS; VIRAL PARTICLES;

TISSUE ENGINEERING;

ANTIINFECTIVE AGENT; NANOMATERIAL; REAGENT;

BACTERIOPHAGE; DRUG DELIVERY SYSTEM; HUMAN; NANOBIOTECHNOLOGY; NONHUMAN; PHAGE THERAPY; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; VIROTHERAPY; VIRUS PARTICLE;

BIONANOMEDICINE; DRUG DELIVERY; PHAGE THERAPY; TISSUE ENGINEERING; VIRUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; BIOMEDICAL TECHNOLOGY; DRUG DELIVERY SYSTEMS; HUMANS; NANOSTRUCTURES; TISSUE ENGINEERING;

EID: 84896402813     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.06.037     Document Type: Review

References (136)

1. M. Sarikaya, C. Tamerler, A.K.-Y. Jen, K. Schulten, and F. Baneyx Molecular biomimetics: Nanotechnology through biology Nat Mater 2 2003 577 585
2. S. Zhang Fabrication of novel biomaterials through molecular self-assembly Nat Biotechnol 21 2003 1171 1178
3. W.R. Browne, and B.L. Feringa Making molecular machines work Nat Nanotechnol 1 2006 25 35
4. S. Wolf, D. Awschalom, R. Buhrman, J. Daughton, S. Von Molnar, and M. Roukes et al. Spintronics: A spin-based electronics vision for the future Science 294 2001 1488 1495
5. T.D. Ladd, F. Jelezko, R. Laflamme, Y. Nakamura, C. Monroe, and J.L. O'Brien Quantum computers Nature 464 2010 45 53
6. N.S. Lewis Toward cost-effective solar energy use Science 315 2007 798 801
7. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 2007 751 760
8. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat Rev Drug Discov 9 2010 615 627
9. M. Ferrari Cancer nanotechnology: Opportunities and challenges Nat Rev Cancer 5 2005 161 171
10. J. Shi, A.R. Votruba, O.C. Farokhzad, and R. Langer Nanotechnology in drug delivery and tissue engineering: From discovery to applications Nano Lett 10 2010 3223 3230
11. T.C. Holmes, S. de Lacalle, X. Su, G. Liu, A. Rich, and S. Zhang Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds Proc Natl Acad Sci U S A 97 2000 6728 6733
12. R.J. Mart, R.D. Osborne, M.M. Stevens, and R.V. Ulijn Peptide-based stimuli-responsive biomaterials Soft Matter 2 2006 822 835
13. A.V. Pinheiro, D. Han, W.M. Shih, and H. Yan Challenges and opportunities for structural DNA nanotechnology Nat Nano 6 2011 763 772
14. P.W. Rothemund, and D.N.A. Folding To create nanoscale shapes and patterns Nature 440 2006 297 302
15. S.M. Douglas, H. Dietz, T. Liedl, B. Högberg, F. Graf, and W.M. Shih Self-assembly of DNA into nanoscale three-dimensional shapes Nature 459 2009 414 418
16. J. Zheng, J.J. Birktoft, Y. Chen, T. Wang, R. Sha, and P.E. Constantinou et al. From molecular to macroscopic via the rational design of a self-assembled 3D DNA crystal Nature 461 2009 74 77
17. S.M. Douglas, I. Bachelet, and G.M. Church A logic-gated nanorobot for targeted transport of molecular payloads Sci Signal 335 2012 831
18. B. Wei, M. Dai, and P. Yin Complex shapes self-assembled from single-stranded DNA tiles Nature 485 2012 623 626
19. K. Matsuura, K. Murasato, and N. Kimizuka Artificial peptide-nanospheres self-assembled from three-way junctions of β-sheet-forming peptides J Am Chem Soc 127 2005 10148 10149
20. N. Amdursky, M. Molotskii, E. Gazit, and G. Rosenman Elementary building blocks of self-assembled peptide nanotubes J Am Chem Soc 132 2010 15632 15636
21. S. Koutsopoulos, L.D. Unsworth, Y. Nagai, and S. Zhang Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold Proc Natl Acad Sci U S A 106 2009 4623 4628
22. R.G. Ellis-Behnke, Y.-X. Liang, S.-W. You, D.K. Tay, S. Zhang, and K.-F. So et al. Nano neuro knitting: Peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision Proc Natl Acad Sci U S A 103 2006 5054 5059
23. M.R. Diehl, K. Zhang, H.J. Lee, and D.A. Tirrell Engineering cooperativity in biomotor-protein assemblies Science 311 2006 1468 1471
24. E. Wang, S.-H. Lee, and S.-W. Lee Elastin-like polypeptide based hydroxyapatite bionanocomposites Biomacromolecules 12 2011 672 680
25. R.L. DiMarco, and S.C. Heilshorn Multifunctional materials through modular protein engineering Adv Mater 24 2012 3923 3940
26. K.S. Straley, and S.C. Heilshorn Independent tuning of multiple biomaterial properties using protein engineering Soft Matter 5 2009 114 124
27. J.C. Liu, and D.A. Tirrell Cell response to RGD density in cross-linked artificial extracellular matrix protein films Biomacromolecules 9 2008 2984 2988
28. A.J. Mieszawska, L.D. Nadkarni, C.C. Perry, and D.L. Kaplan Nanoscale control of silica particle formation via silk-silica fusion proteins for bone regeneration Chem Mater 22 2010 5780 5785
29. M. Manchester, and N.F. Steinmetz Viruses and nanotechnology vol. 327 2009 Springer Berlin
30. S.-W. Lee, C. Mao, C.E. Flynn, and A.M. Belcher Ordering of quantum dots using genetically engineered viruses Science 296 2002 892 895
31. C. Mao, C.E. Flynn, A. Hayhurst, R. Sweeney, J. Qi, and G. Georgiou et al. Viral assembly of oriented quantum dot nanowires Proc Natl Acad Sci U S A 100 2003 6946 6951
32. B.Y. Lee, J. Zhang, C. Zueger, W.-J. Chung, S.Y. Yoo, E. Wang, and C. Mao et al. Virus-based piezoelectric energy generation Nat Nanotechnol 7 2012 351 356
33. W.-J. Chung, J.-W. Oh, K. Kwak, B.Y. Lee, J. Meyer, E. Wang, and J.-W. Oh et al. Biomimetic self-templating supramolecular structures Nature 478 2011 364 368
34. D. Ghosh, Y. Lee, S. Thomas, A.G. Kohli, D.S. Yun, and A.M. Belcher et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer Nat Nanotechnol 7 2012 677 682
35. D. Oh, X. Dang, H. Yi, M.A. Allen, K. Xu, and Y.J. Lee et al. Graphene sheets stabilized on genetically engineered M13 viral templates as conducting frameworks for hybrid energy-storage materials Small 8 2012 1006 1011
36. H. Yi, D. Ghosh, M.-H. Ham, J. Qi, P.W. Barone, and M.S. Strano et al. M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors Nano Lett 12 2012 1176 1183
37. A. Merzlyak, S. Indrakanti, and S.-W. Lee Genetically engineered nanofiber-like viruses for tissue regenerating materials Nano Lett 9 2009 846 852
38. S.Y. Yoo, A. Merzlyak, and S.-W. Lee Facile growth factor immobilization platform based on engineered phage matrices Soft Matter 7 2011 1660
39. X. Dang, H. Yi, M.-H. Ham, J. Qi, D.S. Yun, and R. Ladewski et al. Virus-templated self-assembled single-walled carbon nanotubes for highly efficient electron collection in photovoltaic devices Nat Nanotechnol 6 2011 377 384
40. Y.S. Nam, T. Shin, H. Park, A.P. Magyar, K. Choi, and G. Fantner et al. Virus-templated assembly of porphyrins into light-harvesting nanoantennae J Am Chem Soc 132 2010 1462 1463
41. B. Bhushan Springer handbook of nanotechnology 2010 Springer Berlin
42. J.-W. Yoo, D.J. Irvine, D.E. Discher, and S. Mitragotri Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat Rev Drug Discov 10 2011 521 535
43. T. Dvir, B.P. Timko, D.S. Kohane, and R. Langer Nanotechnological strategies for engineering complex tissues Nat Nanotechnol 6 2010 13 22
44. K.A. Afonin, W.W. Grabow, F.M. Walker, E. Bindewald, M.A. Dobrovolskaia, and B.A. Shapiro et al. Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine Nat Protoc 6 2011 2022 2034
45. S.A. Corr, Y.P. Rakovich, and Y.K. Gun'ko Multifunctional magnetic-fluorescent nanocomposites for biomedical applications Nanoscale Res Lett 3 2008 87 104
46. C. Mao, A. Liu, and B. Cao Virus-based chemical and biological sensing Angew Chem Int Ed 48 2009 6790 6810
47. C.M. Soto, and B.R. Ratna Virus hybrids as nanomaterials for biotechnology Curr Opin Biotechnol 21 2010 426 438
48. S.Y. Lee, J.S. Lim, and M.T. Harris Synthesis and application of virus based hybrid nanomaterials Biotechnol Bioeng 109 2012 16 30
49. S.H. Yang, W.J. Chung, S. McFarland, and S.-W. Lee Assembly of bacteriophage into functional materials Chem Rec 13 2013 43 59
50. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
51. V. Wagner, A. Dullaart, A.-K. Bock, and A. Zweck The emerging nanomedicine landscape Nat Biotechnol 24 2006 1211 1218
52. L. Zhang, F. Gu, J. Chan, A. Wang, R. Langer, and O. Farokhzad Nanoparticles in medicine: Therapeutic applications and developments Clin Pharmacol Ther 83 2007 761 769
53. N.F. Steinmetz Viral nanoparticles as platforms for next-generation therapeutics and imaging devices Nanomedicine 6 2010 634 641
54. E.M. Plummer, and M. Manchester Viral nanoparticles and virus-like particles: Platforms for contemporary vaccine design Wiley Interdiscip Rev Nanomed Nanobiotechnol 3 2011 174 196
55. J.N. Housby, and N.H. Mann Phage therapy Drug Discov Today 14 2009 536 540
56. D. Rhoads, R. Wolcott, M. Kuskowski, B. Wolcott, L. Ward, and A. Sulakvelidze Bacteriophage therapy of venous leg ulcers in humans: Results of a phase I safety trial J Wound Care 18 2009 237 243
57. G.P. Smith, and V.A. Petrenko Phage display Chem Rev 97 1997 391 410
58. S.L. Deutscher Phage display in molecular imaging and diagnosis of cancer Chem Rev 110 2010 3196
59. S.-W. Lee, S.K. Lee, and A.M. Belcher Virus-based alignment of inorganic, organic, and biological nanosized materials Adv Mater 15 2003 689 692
60. M.J. Loessner, and S. Hagens Bacteriophage for biocontrol of foodborne pathogens Curr Pharm Biotechnol 11 2010 58 68
61. M. Mathur, S. Vidhani, and P. Mehndiratta Bacteriophage therapy: An alternative to conventional antibiotics J Assoc Physicians India 51 2003 593 596
62. B. Balogh, J.B. Jones, F. Iriarte, and M. Momol Phage therapy for plant disease control Curr Pharm Biotechnol 11 2010 48
63. S.-W. Lee, and A.M. Belcher Virus-based fabrication of micro- and nanofibers using electrospinning Nano Lett 4 2004 387 390
64. C.R. Merril, D. Scholl, and S.L. Adhya The prospect for bacteriophage therapy in Western medicine Nat Rev Drug Discov 2 2003 489 497
65. R.W. Hendrix Bacteriophages: Evolution of the majority Theor Popul Biol 61 2002 471 480
66. M. Skurnik, M. Pajunen, and S. Kiljunen Biotechnological challenges of phage therapy Biotechnol Lett 29 2007 995 1003
67. G. O'Flynn, R. Ross, G. Fitzgerald, and A. Coffey Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7 Appl Environ Microbiol 70 2004 3417 3424
68. A. Bruttin, and H. Brüssow Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy Antimicrob Agents Chemother 49 2005 2874 2878
69. L. Danelishvili, L.S. Young, and L.E. Bermudez In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium Microb Drug Resist 12 2006 1 6
70. H. Sheng, H.J. Knecht, I.T. Kudva, and C.J. Hovde Application of bacteriophages to control intestinal Escherichia coli O157: H7 levels in ruminants Appl Environ Microbiol 72 2006 5359 5366
71. R. Capparelli, M. Parlato, G. Borriello, P. Salvatore, and D. Iannelli Experimental phage therapy against Staphylococcus aureus in mice Antimicrob Agents Chemother 51 2007 2765 2773
72. M. Merabishvili, J.-P. Pirnay, G. Verbeken, N. Chanishvili, M. Tediashvili, and N. Lashkhi et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials PLoS One 4 2009 e4944
73. R. Capparelli, N. Nocerino, M. Iannaccone, D. Ercolini, M. Parlato, M. Chiara, and N. Lashkhi et al. Bacteriophage therapy of Salmonella enterica: A fresh appraisal of bacteriophage therapy J Infect Dis 201 2010 52 61
74. E. Kutter, D. De Vos, G. Gvasalia, Z. Alavidze, L. Gogokhia, and S. Kuhl et al. Phage therapy in clinical practice: Treatment of human infections Curr Pharm Biotechnol 11 2010 69 86
75. Administration. FAD. Food additives permitted for direct addition to food for human consumption: Bacteriophage preparation. Fed Regist 2006; 71: 47729-47732.
76. R. Carlton, W. Noordman, B. Biswas, E. De Meester, and M. Loessner Bacteriophage P100 for control of Listeria monocytogenes in foods: Genome sequence, bioinformatic analyses, oral toxicity study, and application Regul Toxicol Pharmacol 43 2005 301 312
77. B. Biswas, S. Adhya, P. Washart, B. Paul, A.N. Trostel, and B. Powell et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium Infect Immun 70 2002 204 210
78. S. Matsuzaki, M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, and T. Shuin et al. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage MR11 J Infect Dis 187 2003 613 624
79. K. Markoishvili, G. Tsitlanadze, R. Katsarava, J. Glenn, and A. Sulakvelidze A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds Int J Dermatol 41 2002 453 458
80. A. Wright, C. Hawkins, E. Änggård, and D. Harper A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy Clin Otolaryngol 34 2009 349 357
81. J.R. Clark, and J.B. March Bacteriophages and biotechnology: Vaccines, gene therapy and antibacterials Trends Biotechnol 24 2006 212 218
82. Zhao J, Sulakvelidze A. Policy Brief 10: Bacteriophages: A New Old Biomedical Technology; Extending the Cure, August 2010.
83. R. Withington Regulatory issues for phage based clinical products J Chem Technol Biotechnol 76 2001 673 676
84. S.R. Bhattarai, S.Y. Yoo, S.-W. Lee, and D. Dean Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection Biomaterials 33 2012 5166 5174
85. C.R. Merril, B. Biswas, R. Carlton, N.C. Jensen, G.J. Creed, and S. Zullo et al. Long-circulating bacteriophage as antibacterial agents Proc Natl Acad Sci U S A 93 1996 3188 3192
86. S. Hagens, A. Habel, U. Von Ahsen, A. Von Gabain, and U. Bläsi Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage Antimicrob Agents Chemother 48 2004 3817 3822
87. M.-A. Poul, and J.D. Marks Targeted gene delivery to mammalian cells by filamentous bacteriophage J Mol Biol 288 1999 203 211
88. M. Kolonin, R. Pasqualini, and W. Arap Molecular addresses in blood vessels as targets for therapy Curr Opin Chem Biol 2001 308 313
89. K. Li, Y. Chen, S. Li, H.G. Nguyen, Z. Niu, and S. You et al. Chemical modification of M13 bacteriophage and its application in cancer cell imaging Bioconj Chem 21 2010 1369 1377
90. G.P. Smith Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface Science 228 1985 1315 1317
91. R. Pasqualini, and E. Ruoslahti Organ targeting in vivo using phage display peptide libraries Nature 380 1996 364 366
92. D. Rajotte, W. Arap, M. Hagedorn, E. Koivunen, R. Pasqualini, and E. Ruoslahti Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J Clin Invest 102 1998 430 437
93. H. Bar, I. Yacoby, and I. Benhar Killing cancer cells by targeted drug-carrying phage nanomedicines BMC Biotechnol 8 2008 37
94. W. Arap, R. Pasqualini, and E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
95. D.N. Krag, G.S. Shukla, G.-P. Shen, S. Pero, T. Ashikaga, and S. Fuller et al. Selection of tumor-binding ligands in cancer patients with phage display libraries Cancer Res 66 2006 7724 7733
96. P.-L. Hsiung, J. Hardy, S. Friedland, R. Soetikno, C.B. Du, and A.P. Wu et al. Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy Nat Med 14 2008 454 458
97. J.R. Clark, and J.B. March Bacteriophage-mediated nucleic acid immunisation FEMS Immunol Med Microbiol 40 2004 21 26
98. D. Bedi, J.W. Gillespie, V.A. Petrenko Jr, A. Ebner, M. Leitner, and P. Hinterdorfe et al. Targeted delivery of siRNA into breast cancer cells via phage fusion proteins Mol Pharm 10 2013 551 559
99. A. Hajitou, M. Trepel, C.E. Lilley, S. Soghomonyan, M.M. Alauddin, and F.C. Marini III et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging Cell 125 2006 385 398
100. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, and D.R. Greenwald et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
101. D. Frenkel, and B. Solomon Filamentous phage as vector-mediated antibody delivery to the brain Proc Natl Acad Sci U S A 99 2002 5675 5679
102. S. Shukla, A.L. Ablack, A.M. Wen, K.L. Lee, J.D. Lewis, and N.F. Steinmetz Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X Mol Pharm 10 2013 33 42
103. S. Qazi, L.O. Liepold, M.J. Abedin, B. Johnson, P. Prevelige, and J.A. Frank et al. P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents Mol Pharm 10 2013 11 17
104. A. Sergeeva, M.G. Kolonin, J.J. Molldrem, R. Pasqualini, and W. Arap Display technologies: Application for the discovery of drug and gene delivery agents Adv Drug Deliv 58 2006 1622 1654
105. J. Zou, M.T. Dickerson, N.K. Owen, L.A. Landon, and S.L. Deutscher Biodistribution of filamentous phage peptide libraries in mice Mol Biol Rep 31 2004 121 129
106. K.C. Brown New approaches for cell-specific targeting: Identification of cell-selective peptides from combinatorial libraries Curr Opin Chem Biol 4 2000 16 21
107. R. Langer, and D.A. Tirrell Designing materials for biology and medicine Nature 428 2004 487 492
108. M. Lutolf, and J. Hubbell Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat Biotechnol 23 2005 47 55
109. S.J. Hollister Porous scaffold design for tissue engineering Nat Mater 4 2005 518 524
110. J.K. Nicholson, E. Holmes, J.C. Lindon, and I.D. Wilson The challenges of modeling mammalian biocomplexity Nat Biotechnol 22 2004 1268 1274
111. F. Pampaloni, E.G. Reynaud, and E.H. Stelzer The third dimension bridges the gap between cell culture and live tissue Nat Rev Mol Cell Biol 8 2007 839 845
112. Z. Ma, M. Kotaki, R. Inai, and S. Ramakrishna Potential of nanofiber matrix as tissue-engineering scaffolds Tissue Eng 11 2005 101 109
113. M.M. Stevens, and J.H. George Exploring and engineering the cell surface interface Science 310 2005 1135 1138
114. F. Brandl, F. Sommer, and A. Goepferich Rational design of hydrogels for tissue engineering: Impact of physical factors on cell behavior Biomaterials 28 2007 134 146
115. C.J. Bettinger, R. Langer, and J.T. Borenstein Engineering substrate topography at the micro and nanoscale to control cell function Angew Chem Int Ed 48 2009 5406 5415
116. S.I. Fraley, Y. Feng, R. Krishnamurthy, D.-H. Kim, A. Celedon, and G.D. Longmore et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility Nat Cell Biol 12 2010 598 604
117. A.J. Engler, S. Sen, H.L. Sweeney, and D.E. Discher Matrix elasticity directs stem cell lineage specification Cell 126 2006 677 689
118. D.T. Butcher, T. Alliston, and V.M. Weaver A tense situation: Forcing tumour progression Nat Rev Cancer 9 2009 108 122
119. J. Fu et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates Nat Methods 7 2010 733 736
120. J. Luckanagul, L.A. Lee, Q.L. Nguyen, P. Sitasuwan, X. Yang, and T. Shazly et al. Porous alginate hydrogel functionalized with virus as three-dimensional scaffolds for bone differentiation Biomacromolecules 13 2012 3949 3958
121. X. Zan, P. Sitasuwan, J. Powell, T.W. Dreher, and Q. Wang Polyvalent display of RGD motifs on turnip yellow mosaic virus for enhanced stem cell adhesion and spreading Acta Biomater 8 2012 2978 2985
122. A. Merzlyak, and S.-W. Lee Engineering phage materials with desired peptide display: Rational design sustained through natural selection Bioconj Chem 20 2009 2300 2310
123. J. Rong, L. Lee, K. Li, B. Harp, C. Mello, and Z. Niu et al. Oriented cell growth on self-assembled bacteriophage M13 thin films Chem Commun 2008 5185 5187
124. W.J. Chung, A. Merzlyak, S.Y. Yoo, and S.W. Lee Genetically engineered liquid-crystalline viral films for directing neural cell growth Langmuir 26 2010 9885 9890
125. L. Wu, L.A. Lee, Z. Niu, S. Ghoshroy, and Q. Wang Visualizing cell extracellular matrix (ECM) deposited by cells cultured on aligned bacteriophage M13 thin films Langmuir 27 2011 9490 9496
126. H. Zhu, B. Cao, Z. Zhen, A.A. Laxmi, D. Li, and S. Liu et al. Controlled growth and differentiation of MSCs on grooved films assembled from monodisperse biological nanofibers with genetically tunable surface chemistries Biomaterials 32 2011 4744 4752
127. T. He, G. Abbineni, B. Cao, and C. Mao Nanofibrous bio-inorganic hybrid structures formed through self-assembly and oriented mineralization of genetically engineered phage nanofibers Small 6 2010 2230 2235
128. P. Sitasuwan, L.A. Lee, P. Bo, E.N. Davis, Y. Lin, and Q. Wang A plant virus substrate induces early upregulation of BMP2 for rapid bone formation Integr Biol 4 2012 651 660
129. J. Wang, L. Wang, X. Li, and C. Mao Virus activated artificial ECM induces the osteoblastic differentiation of mesenchymal stem cells without osteogenic supplements Sci Rep 3 2013 1242
130. Q. Wang, T. Lin, L. Tang, J.E. Johnson, and M. Finn Icosahedral virus particles as addressable nanoscale building blocks Angew Chem Int Ed 41 2002 459 462
131. M.E. Farkas, I.L. Aanei, C.R. Behrens, G.J. Tong, S.T. Murphy, and J.P. O'Neil et al. PET imaging and biodistribution of chemically modified bacteriophage MS2 Mol Pharm 10 2012 69 76
132. C. Sachse, J.Z. Chen, P.-D. Coureux, M.E. Stroupe, M. Fändrich, and N. Grigorieff High-resolution electron microscopy of helical specimens: A fresh look at tobacco mosaic virus J Mol Biol 371 2007 812 835
133. A. Kendall, M. McDonald, W. Bian, T. Bowles, S.C. Baumgarten, and J. Shi et al. Structure of flexible filamentous plant viruses J Virol 82 2008 9546 9554
134. B. Hu, W. Margolin, I.J. Molineux, and J. Liu The bacteriophage T7 virion undergoes extensive structural remodeling during infection Science 339 2013 576 579
135. M. Carrillo-Tripp, C.M. Shepherd, I.A. Borelli, S. Venkataraman, G. Lander, and P. Natarajan et al. VIPERdb2: An enhanced and web API enabled relational database for structural virology Nucleic Acids Res 37 2009 D436 D442
136. V.A. Kostyuchenko, P.G. Leiman, P.R. Chipman, S. Kanamaru, M.J. van Raaij, and F. Arisaka Three-dimensional structure of bacteriophage T4 baseplate Nat Struct Mol Biol 10 2003 688 693